Literature DB >> 24854640

Kidney regeneration in mammals.

Hai-Chun Yang1, Shao-Jun Liu, Agnes B Fogo.   

Abstract

BACKGROUND: Several organs such as the skin and liver have a great capacity for regeneration. However, many approaches only delay the progression of end-stage kidney disease and do not achieve efficient long-term stabilization, let alone regeneration.
SUMMARY: In mammals, the kidney has an innate but limited capacity for regeneration which can only modify the nephron structure and function but not increase the nephron number. Several clinical and animal studies have indicated that functional improvements and/or structural regression can occur in chronic kidney disease. Cell reconstitution, matrix remodeling, and tissue reorganization are major mechanisms for kidney regeneration. Current approaches achieve only partial kidney regeneration, but this does not occur in all animals and is not sustained in the long term. Multipronged and early interventions are future choices for the induction of kidney regeneration. KEY MESSAGES: Kidney regeneration in mammals is feasible but limited and may be enhanced by multitargeting key mechanisms.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24854640      PMCID: PMC4337834          DOI: 10.1159/000360661

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  27 in total

1.  From Proteus to Prometheus: learning from fish to modulate regeneration.

Authors:  Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

2.  ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.

Authors:  A Remuzzi; E Gagliardini; F Sangalli; M Bonomelli; M Piccinelli; A Benigni; G Remuzzi
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

3.  Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.

Authors:  Xiu-Bin Liang; Li-Jun Ma; Takashi Naito; Yihan Wang; Michael Madaio; Roy Zent; Ambra Pozzi; Agnes B Fogo
Journal:  J Am Soc Nephrol       Date:  2006-06-21       Impact factor: 10.121

4.  Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis.

Authors:  Benjamin S Scruggs; Yiqin Zuo; Ellen Donnert; Lijun Ma; John F Bertram; Agnes B Fogo
Journal:  Am J Pathol       Date:  2011-03-03       Impact factor: 4.307

5.  Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.

Authors:  Warangkana Pichaiwong; Kelly L Hudkins; Tomasz Wietecha; Tri Q Nguyen; Chiraporn Tachaudomdach; Wei Li; Bardia Askari; Takahisa Kobayashi; Kevin D O'Brien; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

Review 6.  Cellular pathophysiology of ischemic acute kidney injury.

Authors:  Joseph V Bonventre; Li Yang
Journal:  J Clin Invest       Date:  2011-11-01       Impact factor: 14.808

7.  Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes.

Authors:  Zalan Nemeth; Gabor Kokeny; Maria Godo; Miklós Mózes; László Rosivall; Marie-Luise Gross; Eberhard Ritz; Péter Hamar
Journal:  Nephrol Dial Transplant       Date:  2009-08-08       Impact factor: 5.992

8.  Uncharted waters: nephrogenesis and renal regeneration in fish and mammals.

Authors:  Alan J Davidson
Journal:  Pediatr Nephrol       Date:  2011-02-19       Impact factor: 3.714

9.  Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease.

Authors:  Jeffrey W Pippin; Matthew A Sparks; Sean T Glenn; Sandra Buitrago; Thomas M Coffman; Jeremy S Duffield; Kenneth W Gross; Stuart J Shankland
Journal:  Am J Pathol       Date:  2013-06-14       Impact factor: 4.307

10.  Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.

Authors:  Daniela Macconi; Fabio Sangalli; Maria Bonomelli; Sara Conti; Lucia Condorelli; Elena Gagliardini; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

View more
  3 in total

Review 1.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

Review 2.  Hydrogel-Based Cell Therapies for Kidney Regeneration: Current Trends in Biofabrication and In Vivo Repair.

Authors:  Katja Jansen; Carl C L Schuurmans; Jitske Jansen; Rosalinde Masereeuw; Tina Vermonden
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  IL-36α Regulates Tubulointerstitial Inflammation in the Mouse Kidney.

Authors:  Osamu Ichii; Junpei Kimura; Tadashi Okamura; Taro Horino; Teppei Nakamura; Hayato Sasaki; Yaser Hosny Ali Elewa; Yasuhiro Kon
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.